JPRN-UMIN000006526
Completed
未知
Antihypertensive Treatment in Acute Cerebral Hemorrhage-II - ATACH-II
niversity of Minnesota National Cerebral and Cardiovascular Center0 sites1,000 target enrollmentOctober 14, 2011
ConditionsCerebral Hemorrhage
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cerebral Hemorrhage
- Sponsor
- niversity of Minnesota National Cerebral and Cardiovascular Center
- Enrollment
- 1000
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
We conducted a multicenter trial where eligible subjects with ICH were randomized to intensive (<140 mm Hg) and standard (<180 mm Hg) SBP reduction in a 1:1 ratio <4.5h. The primary outcome of death and disability was ascertained at 3-M post randomization. Compared with standard SBP reduction, intensive SBP reduction in patients with ICH did not lower the rate of death and disability despite achieving a small magnitude reduction in hematoma expansion.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.ICH is due to previously known neoplasms, AVM, or aneurysms 2\.Intracerebral hematoma considered to be related to trauma 3\.ICH located in infratentorial regions such as pons or cerebellum 4\.IVH associated with intraparenchymal hemorrhage and blood completely fills one lateral ventricle or more than half of both ventricles 5\.Patient to receive immediate surgical evacuation 6\.Current pregnancy, parturition within previous 30 days or active lactation 7\.Use of warfarin within the last 5 days and INR \>4 8\.A platelet count less than 50,000/mm3 9\.Known sensitivity to nicardipine 10\.Pre\-morbid disability requiring assistance in ambulation or activities of daily living 11\.Subjects living will precludes aggressive ICU management 12\.Subject is currently participating in another interventional clinical trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Phase 3
Antihypertensive Treatment of Acute Cerebral Hemorrhage-IIIntracerebral HemorrhageNCT01176565University of Minnesota1,000
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral HemorrhageIntracerebral HemorrhageNCT06255977Beijing Tiantan Hospital240
Completed
Phase 1
Antihypertensive Treatment in Acute Cerebral HemorrhageIntracerebral HemorrhageHypertensionStrokeNCT00415610University of Minnesota60
Completed
Phase 3
China Antihypertensive Trial in Acute Ischemic Stroke IIAcute Ischemic StrokeNCT03479554Tulane University4,810
Unknown
Phase 4
Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking AgentsTraumatic Brain InjuryIntracranial HypertensionNCT02404779University Hospital, Clermont-Ferrand34